Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MRNA expression profiles of 223 cancer cell lines including newly established ones

ABSTRACT: mRNA expression profiles of 223 cancer cell lines including newly established ones

PROVIDER: PRJNA722281 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

mRNA expression profiles of 223 cancer cell lines including newly established ones

Project description:Establishment and molecular characterization of 239 peritoneally-metastatic cancer cell lines from 170 patients’ ascites in 11 kinds of cancers mainly consisted of gastric, pancreatic, and ovarian cancer. We performed comparative transcriptome analyses using microarrays between our established cancer cell lines and cell-bank derived cancer cell lines

2023-02-21 | GSE172159 | GEO

mRNA expression profiles of newly established 49 gastric cancer cell lines.

Project description:mRNA expression profiles of newly established 49 gastric cancer cell lines.

| PRJNA722410 | ENA

Bradyrhizobium sp. USDA 223 isolate:USDA 223

Project description:Bradyrhizobium sp. USDA 223 isolate:USDA 223 Genome sequencing

| PRJNA1115348 | ENA

Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers

Project description:Newly established gastrointestinal cancer cell lines retain the genomic and immunophenotypic landscape of their parental cancers

| PRJNA634242 | ENA

mRNA expression profiles of newly established 49 gastric cancer cell lines.

Project description:Establishment and molecular characterization of 49 peritoneally-metastatic gastric cancer cell lines from 18 patients’ ascites. We performed comprehensive transcriptome analyses using microarrays of our established gastric cancer cell lines.

2023-04-01 | GSE172197 | GEO

regulatory changes induced by miR-223 in a monocyte/macrophage cell line.

Project description:We used a multi-omics approach combining transcriptomics, proteomics and metabolomics to study the impact of over-expression and inhibition of the microRNA miR-223, a pleiotropic regulator of metabolic-related disease, in the RAW monocyte-macrophage cell line. We analyzed the levels of proteins, mRNAs, and metabolites in order to identify genes involved in miR-223 regulation, to determine candidate disease biomarkers and potential therapeutic targets. We observed that both up- and down-regulation of miR-223 induced profound changes in the mRNA, protein and metabolite profiles in RAW cells. Microarray-based transcriptomics evidenced a change in 120 genes that were linked predominantly to histone acetylation, bone remodeling and RNA regulation. In addition, 30 out the 120 genes encoded long noncoding RNAs. The nanoLC-MS/MS revealed that 52 proteins were significantly altered when comparing scramble, pre- and anti-miR-223 treatments. Sixteen out of the mRNAs coding these proteins genes are predicted to have binding sites for miR-223. CARM-1, Ube2g2, Cactin and Ndufaf4 were confirmed to be miR-223 targets by western blotting. Analyses using Gene Ontology annotations evidenced association with cell death, splicing and stability of mRNAs, bone remodeling and cell metabolism. miR-223 alteration changed the expression of CARM-1, Ube2g2, Cactin and Ndufaf4 during osteoclastogenesis and macrophage, indicating that these genes are potential biomarkers of these processes. The most important discriminant metabolites found in the metabolomics study were found to be hydrophilic amino acids, carboxylic acids linked to metabolism and pyrimidine nucleotides, indicating that changes in miR-223 expression alter the metabolic profile of cells, and may affect their apoptotic and proliferative state.

2021-03-29 | PXD009844 | Pride

miR-223 in esophageal adenocarcinoma carcinogenesis

Project description:miR-223 is step-wise increasingly up-regulated in the normal esophagus - Barrett's esophagus -esophageal adenocarcinoma carcinoma sequence. In this study, we aimed to determine the function of miR-223 in esophageal adenocarcinoma carcinogenesis.

2013-02-07 | GSE44120 | GEO

Biological and genetic characterization of a newly established human external auditory carcinoma cell line, SCEACono2

Project description:Biological and genetic characterization of a newly established human external auditory carcinoma cell line, SCEACono2

| PRJNA1003126 | ENA

miR-223 Bone Marrow Derived Eosinophils

Project description:Gene expression profiling of bone marrow derived eosinophils from miR-223 wildtype or miR-223 deficient mice

2012-08-25 | E-MEXP-3350 | biostudies-arrayexpress

A multi-omics analysis of the regulatory changes induced by miR-223 in a monocyte/macrophage cell line

Project description:We used a multi-omics approach to study the impact of miR-223 in the RAW cell line. We evidenced changes linked to cell death, histone acetylation, bone remodeling, RNA regulation. Changes in miR-223 expression altered the metabolic profile of cells including nucleotides. miR-223 impacted NF-kB levels, macrophage differentiation and osteoclastogenesis.

2018-10-11 | GSE121077 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data